Proliferative response against cytomegalovirus and prognosis of renal transplant and IgA nephropathy patients.
Sakamaki
T
T
Sakura National Hospital, National Kidney Transplantation Center, Chiba, Japan.
Kashiwabara
H
H
Omori
K
K
Nagata
N
N
Hachisu
T
T
Tateno
S
S
Shishido
H
H
Yokoyama
T
T
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000302:isolation & purification*; D002478:Cells, Cultured; D003404:Creatinine / Q000097:blood; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D005922:Glomerulonephritis, IGA / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology* / Q000502:physiology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D011379:Prognosis
D000914:Antibodies, Viral; D000956:Antigens, Viral; D007166:Immunosuppressive Agents; D003404:Creatinine